Pyruvate kinase M2 promotes de novo serine synthesis to sustain mTORC1 activity and cell proliferation
- 16 April 2012
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 109 (18), 6904-6909
- https://doi.org/10.1073/pnas.1204176109
Abstract
Despite the fact that most cancer cells display high glycolytic activity, cancer cells selectively express the less active M2 isoform of pyruvate kinase (PKM2). Here we demonstrate that PKM2 expression makes a critical regulatory contribution to the serine synthetic pathway. In the absence of serine, an allosteric activator of PKM2, glycolytic efflux to lactate is significantly reduced in PKM2-expressing cells. This inhibition of PKM2 results in the accumulation of glycolytic intermediates that feed into serine synthesis. As a consequence, PKM2-expressing cells can maintain mammalian target of rapamycin complex 1 activity and proliferate in serine-depleted medium, but PKM1-expressing cells cannot. Cellular detection of serine depletion depends on general control nonderepressible 2 kinase-activating transcription factor 4 (GCN2-ATF4) pathway activation and results in increased expression of enzymes required for serine synthesis from the accumulating glycolytic precursors. These findings suggest that tumor cells use serine-dependent regulation of PKM2 and GCN2 to modulate the flux of glycolytic intermediates in support of cell proliferation.Keywords
This publication has 46 references indexed in Scilit:
- Functional genomics reveal that the serine synthesis pathway is essential in breast cancerNature, 2011
- Pyruvate Kinase M2 Is a PHD3-Stimulated Coactivator for Hypoxia-Inducible Factor 1Cell, 2011
- Metabolomic Analysis and Visualization Engine for LC−MS DataAnalytical Chemistry, 2010
- The GCN2-ATF4 pathway is critical for tumour cell survival and proliferation in response to nutrient deprivationThe EMBO Journal, 2010
- Evaluation of thieno[3,2-b]pyrrole[3,2-d]pyridazinones as activators of the tumor cell specific M2 isoform of pyruvate kinaseBioorganic & Medicinal Chemistry Letters, 2010
- Metabolomic Analysis via Reversed-Phase Ion-Pairing Liquid Chromatography Coupled to a Stand Alone Orbitrap Mass SpectrometerAnalytical Chemistry, 2010
- Evaluation of Substituted N,N′-Diarylsulfonamides as Activators of the Tumor Cell Specific M2 Isoform of Pyruvate KinaseJournal of Medicinal Chemistry, 2009
- HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancerNature, 2009
- Systems-level metabolic flux profiling identifies fatty acid synthesis as a target for antiviral therapyNature Biotechnology, 2008
- An Integrated Stress Response Regulates Amino Acid Metabolism and Resistance to Oxidative StressMolecular Cell, 2003